(Q34742191)

4 August 2017

0 references

1 reference

title

Short-term treatment of gastroesophageal reflux disease (English)

1 reference

gastroesophageal reflux disease

4 August 2017

main subject

0 references

5

A Pali S Hungin

1 reference

4 August 2017

3

Joseph Lau

1 reference

4 August 2017

Bart van Pinxteren

1

1 reference

4 August 2017

Mattijs E Numans

series ordinal

2

1 reference

4 August 2017

Niek J de Wit

series ordinal

4

1 reference

4 August 2017

Peter A L Bonis

series ordinal

6

1 reference

4 August 2017

publication date

1 September 2003

1 reference

Journal of General Internal Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

18

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

755-763

1 reference

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Heartburn treatment in primary care: randomised, double blind study for 8 weeks

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

7 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

7 July 2018

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2003.20833.X

Gastro-oesophageal reflux symptoms--clinical findings and effect of ranitidine treatment

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Heartburn requiring frequent antacid use may indicate significant illness

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Summing up evidence: one answer is not always enough.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus"

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Heartburn and globus in apparently healthy people.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

7 July 2018

Heartburn--the acid test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Cimetidine suspension in patients with stage 0 gastro-oesophageal reflux disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Famotidine (20 mg) b.d. relieves gastrooesophageal reflux symptoms in patients without erosive oesophagitis. Famotidine/GERD Investigation Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Symptomatic gastroesophageal reflux: incidence and precipitating factors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Effect of cimetidine in symptomatic gastro-oesophageal reflux

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2003.20833.X

Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494910

Controlled trial of cimetidine in reflux esophagitis

26 October 2018

1 reference

12 December 2020

Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux

1 reference

12 December 2020

Cimetidine for the treatment of symptomatic gastro-oesophageal reflux

1 reference

12 December 2020

Cimetidine in gastro-oesophageal reflux

1 reference

12 December 2020

Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease

1 reference

12 December 2020

Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease

1 reference

12 December 2020

Do endoscopic findings influence response to H2 antagonist therapy for gastroesophageal reflux disease?

1 reference

12 December 2020

Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial

1 reference

12 December 2020

Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease

1 reference

12 December 2020

Some statistical methods for combining experimental results

1 reference

12 December 2020

Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire

1 reference

12 December 2020

[Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms]

1 reference

12 December 2020

Empiric therapy for gastroesophageal reflux disease

1 reference

12 December 2020

Heartburn, oesophagitis and Barrett's oesophagus in self-medicating patients in general practice

1 reference

12 December 2020

Omeprazole as a diagnostic tool in gastroesophageal reflux disease

1 reference

12 December 2020

One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease

1 reference

12 December 2020

Gastro-oesophageal reflux disease

1 reference

12 December 2020

Esophageal hypersensitivity may be a major cause of heartburn

1 reference

12 December 2020

10.1046/J.1525-1497.2003.20833.X

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference